1-2 of 2
Xiaotong Li
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Prospective real-world evaluation of t(11;14) prevalence and disease biology in multiple myeloma: MEDICI study analysis

Open Access
Clinical Trials & Observations
Andrew Spencer, Maria Gavriatopoulou, Daniel Coriu, Anna Lysén, Norma C Gutierrez, Fernando Escalante, Dorotea Fantl, Roman Hajek, Fernanda Seguro, Gurbakhash Kaur, Rosane Isabel Bittencourt, Sandra Bašić-Kinda, Michael P Chu, Hana Safah, Joaquín Martínez-López, Edvan de Queiroz Crusoé, Danielle Leao Cordeiro De Farias, Massimo Offidani, Elham Askari, Omur Gokmen SEVINDIK, Vladimir Maisnar, Chieh-Lin Jerry Teng, Olivia Hughes, Rebekah Taylor, Kristin Lehn, Dai Feng, Raphaële Thiébaut-Millot, Xiaotong Li, Lauren Murray, Paul Jung, Emily L Rossi, Sarah Kongpachith, Alexander Nichol, Jeremy A Ross, Carlos Hader
Journal: Blood Advances
Blood Adv bloodadvances.2025017214.
https://doi.org/10.1182/bloodadvances.2025017214
Published: 2025
Includes: Supplemental data
Journal Articles

Treating relapsed/refractory mature T- and NK-cell neoplasms with tislelizumab: a multicenter open-label phase 2 study

Free
Clinical Trials & Observations
Emmanuel Bachy, Kerry J. Savage, Huiqiang Huang, Yok-Lam Kwong, Giuseppe Gritti, Qingyuan Zhang, Anna Marina Liberati, Junning Cao, Haiyan Yang, Siguo Hao, Jianda Hu, Keshu Zhou, Mario Petrini, Filomena Russo, Huilai Zhang, Wei Sang, Jie Ji, Andrés José María Ferreri, Gandhi Laurent Damaj, Hui Liu, Wei Zhang, Xiaoyan Ke, Chiara Ghiggi, Sha Huang, Xiaotong Li, Hui Yao, Jason Paik, William Novotny, Wenxiao Zhou, Hongjie Zhu, Pier Luigi Zinzani
Journal: Blood Advances
Blood Adv (2023) 7 (16): 4435–4447.
https://doi.org/10.1182/bloodadvances.2022009575
Published: 2023
Includes: Supplemental data